by TractManager | Apr 17, 2020 | Health Technology Assessment
Focus of the Report: For use of botulinum toxin (BTX) for Raynaud phenomenon (RP).Technology Description: BTX has been investigated as a treatment for various chronic painful conditions because of its potential to reduce muscle tension and modulate pain receptor...
by TractManager | Apr 14, 2020 | Health Technology Assessment
Focus of the Report: The use of transabdominal cervical cerclage (TAC) for treatment of cervical insufficiency to prevent preterm delivery (PTD) or miscarriage. Technology Description: TAC involves the placement of sutures to reinforce the cervix using a...
by TractManager | Apr 13, 2020 | Emerging Technology Report
Reblozyl is an erythroid maturation agent administered via subcutaneous injection indicated for the treatment of patients with transfusion-dependent beta thalassemia. This recombinant fusion protein is believed to help immature cells develop into red blood cells,...
by TractManager | Apr 13, 2020 | COVID-Articles, Emerging Technology Report
Lopinavir/ritonavir is an oral antiretroviral protease inhibitor combination agent under investigation for the treatment of COVID-19. Lopinavir/ritonavir is FDA approved for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in...
by TractManager | Apr 9, 2020 | COVID-Articles, Emerging Technology Report
Convalescent plasma is a form of passive antibody therapy that is under investigation for the treatment of COVID-19. Convalescent plasma is collected from patients who have recovered from COVID-19 and administered to patients with active, symptomatic disease via...
Recent Comments